title: Prospective treatment of age-related diseases by slowing down aging.
abstract: Atherosclerosis, hypertension, obesity, diabetic complications, cancer, benign prostate hyperplasia, Alzheimer and Parkinson diseases, age-related macular degeneration, osteoarthritis, osteoporosis, and seborrheic keratosis are strongly associated with aging, implying a common underlying process. Each disease is treated separately and, in most cases, symptomatically. Suppression of aging itself should delay or treat all age-related diseases, thus increasing healthy life span and maximal longevity. But, is it possible to slow down aging? Recent evidence indicates that the target of rapamycin signaling pathway is involved in cellular senescence and organismal aging. Preclinical and clinical studies demonstrated the therapeutic effects of rapamycin in diverse age-related diseases. One simple reason why a single drug is indicated for so many age-related diseases is that it inhibits the aging process.
authors: Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. blagosklonny@oncotarget.com
authors: Mikhail V
authors: MV
authors: Blagosklonny
mesh_terms: D000375:Aging / Q000187:drug effects* / Q000473:pathology; D031204:Caloric Restriction; D004194:Disease; D006801:Humans; D008136:Longevity / Q000187:drug effects; D012060:Rejuvenation; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism
chemical_list: D058570:TOR Serine-Threonine Kinases